Well, It seems like forever. Yet, Monday morning is the official kickoff for US Iluvien. I think it's a pretty good
idea that Alimera starts with testimonials by retina specialists, and a follow up Q&A session. US distribution and sales should start to move the needle for Alimera and pSivida. By the end of the year, more data on veg-f effectiveness ( or lack thereof) on DME should accelerate the attitude towards Iluvien. It starts now.